The Pharmacological Profile of Cyclin-dependent Kinase (CDK) 4/6 Inhibitors: Clinical Management of Toxicity and Drug Interactions Related to CDK 4/6 Inhibitor-based Treatment in A...

by Vasiliki Tzelepi C., Aristeidis Gogadis T., Christos Adamidis K., Timotheadou Eleni T.
Published 2020-04-01

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Coopera...

by Briasoulis Evangelos, Samantas Epaminondas, Makatsoris Thomas, Timotheadou Eleni, Kosmidis Paris, Kalofonos Haralabos P, Fountzilas George, Bamias Aristotelis, Papadimitriou Christos, Aravantinos Gerasimos, Linardou Helena, Bafaloukos Dimitrios, Christodoulou Christos, Papakostas Pavlos, Pectasides Dimitrios, Dimopoulos Athanasios M
Published 2010-01-01

Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

by Christodoulou Christos, Skolarikos Andreas, Xanthakis Ioannis, Stravodimos Kostas, Anastasiou Ioannis, Kontovinis Loukas, Andreadis Charalambos, Papazisis Kostas, Timotheadou Eleni, Malettou Lia, Lainakis George, Lampaki Sofia, Karadimou Alexandra, Bamias Aristotelis, Syrigos Kostas, Papandreou Christos, Razi Evangelia, Dafni Urania, Fountzilas George, Dimopoulos Meletios A
Published 2010-02-01

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with coll...

by Pectasides Dimitrios, Papaxoinis George, Kalogeras Konstantine T, Eleftheraki Anastasia G, Xanthakis Ioannis, Makatsoris Thomas, Samantas Epaminondas, Varthalitis Ioannis, Papakostas Pavlos, Nikitas Nikitas, Papandreou Christos N, Pentheroudakis George, Timotheadou Eleni, Koutras Angelos, Sgouros Joseph, Bafaloukos Dimitrios, Klouvas George, Economopoulos Theofanis, Syrigos Konstantinos N, Fountzilas George
Published 2012-06-01

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

by Fountzilas George, Valavanis Christos, Kotoula Vassiliki, Eleftheraki Anastasia G, Kalogeras Konstantine T, Tzaida Olympia, Batistatou Anna, Kronenwett Ralf, Wirtz Ralph M, Bobos Mattheos, Timotheadou Eleni, Soupos Nikolaos, Pentheroudakis George, Gogas Helen, Vlachodimitropoulos Dimitrios, Polychronidou Genovefa, Aravantinos Gerasimos, Koutras Angelos, Christodoulou Christos, Pectasides Dimitrios, Arapantoni Petroula
Published 2012-01-01